Syntiron on LinkedIn: Syntiron is excited to partner with CARB-X to develop one of our AMR…
Summary
Syntiron is excited to partner with CARB-X to develop one of our AMR vaccine candidates as a maternal immunization to prevent neonatal sepsis. Learn more about this and other important work to combat antimicrobial resistance here:
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected